Search

everythinglearnresearchcommunity

for

Search:↓

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

A new compound shows promise as a topical treatment for hair loss.

Combining MSM with MAP significantly promotes hair growth.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Korean medicine effectively treats febrile alopecia, shifting focus from genetic to febrile causes.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Clipping is the best method to prepare rats for studying hair loss from chemotherapy because it causes less skin damage and effectively gets hair to the right growth phase.

Young rats are better for testing hair loss treatments after chemotherapy.

Low-level laser therapy combined with Neoptide improved hair regrowth better than either treatment alone in rats.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Men with alopecia areata have different body fat distribution compared to healthy men.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Omics techniques are needed to understand the scalp microbiome's role in alopecia areata for new treatments.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Keratin 17 is crucial for early hair strength and cell survival.

Minoxidil-loaded NLC gel shows potential for effective alopecia treatment.